DabeleaDMayer-DavisEJSaydahS. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311:1778-1786.
2.
ImperatoreGBoyleJPThompsonTJ. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35:2515-2520.
3.
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(suppl 1):S13-S22.
4.
SinhaRFischGTeagueB. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-810.
5.
NowickaPSantoroNLiuH. Utility of hemoglobin a1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34:1306-1311.
6.
ChanCLPyleLNewnesLNadeauKJZeitlerPSKelseyMM.Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth. J Clin Endocrinol Metab. 2015;100:902-910.
7.
MenkeACasagrandeSCowieCC.Prevalence of diabetes in adolescents aged 12 to 19 years in the United States, 2005-2014. JAMA. 2016;316:344-345.
8.
DeFronzoRAAbdul-GhaniMA.Preservation of beta-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011;96:2354-2366.
9.
WeissR.Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr Diabetes. 2007;8(suppl 9):70-75.
10.
WeissRTaksaliSETamborlaneWVBurgertTSSavoyeMCaprioS.Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902-909.
11.
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3:866-875.
12.
FranchiniSSavinoAMarcovecchioMLTuminiSChiarelliFMohnA.The effect of obesity and type 1 diabetes on renal function in children and adolescents. Pediatr Diabetes. 2015;16:427-433.
13.
NguyenSMcCullochCBrakemanPPortaleAHsuCY.Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics. 2008;121:37-45.
14.
KnowlerWCBarrett-ConnorEFowlerSE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
15.
QuinnSMBaurLAGarnettSPCowellCT.Treatment of clinical insulin resistance in children: a systematic review. Obes Rev. 2010;11:722-730.
16.
SavoyeMCaprioSDziuraJ. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care. 2014;37:317-324.
17.
American Diabetes Association. (5) Prevention or delay of type 2 diabetes. Diabetes Care. 2015;38(suppl):S31-S32.